| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.47 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.46 | 0.009 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |